Life Sciences

Lilly’s Jaypirca leads the leukemia trail with FDA approval

Lilly’s Jaypirca leads the leukemia trail with FDA appr...

Dec 6, 2023

In the highly competitive landscape of BTK inhibitors for blood cancer treatment...

Merus Faces Setback Following Interim Report for Lung Cancer Therapy

Merus Faces Setback Following Interim Report for Lung C...

Dec 6, 2023

Merus, a biopharmaceutical company, confronted a significant setback following a...

Merck’s Evobrutinib Encounters Setbacks in MS Trials Amid BTK Inhibitor Challenges

Merck’s Evobrutinib Encounters Setbacks in MS Trials Am...

Dec 6, 2023

Merck KGaA’s foray into the competitive BTK inhibitor space has hit a roadblock,...

Roche’s $2.7 Billion Move into the Obesity Market Acquisition of Carmot Therapeutics

Roche’s $2.7 Billion Move into the Obesity Market Acqui...

Dec 4, 2023

Roche has made a resounding entry into the obesity market with a whopping upfron...

Lung Cancer Data from AbbVie Paves Way for Accelerated ADC Approval, Falls Below Initial Benchmark

Lung Cancer Data from AbbVie Paves Way for Accelerated ...

Dec 2, 2023

AbbVie is actively seeking accelerated approval for its promising c-Met antibody...

Amgen Expands Amazon Partnership to Seek Generative AI Solutions

Amgen Expands Amazon Partnership to Seek Generative AI ...

Nov 30, 2023

In a concerted effort to enhance the discovery and manufacturing processes of ph...

Roivant Bids Farewell to Lupus Treatment Following Phase 2 Failure

Roivant Bids Farewell to Lupus Treatment Following Phas...

Nov 30, 2023

Roivant CEO Matt Gline had never been too confident of lupus drug brepocitinib. ...

In a late-stage trial, GSK’s blood cancer medication achieves its main objective

In a late-stage trial, GSK’s blood cancer medication ac...

Nov 30, 2023

GlaxoSmithKline (GSK) has achieved a significant breakthrough in its efforts to ...

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

Nov 28, 2023

GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt de...

AstraZeneca’s Strategic Leap into KRAS G12D with Chinese Biotech Collaboration

AstraZeneca’s Strategic Leap into KRAS G12D with Chines...

Nov 28, 2023

AstraZeneca has secured a significant deal in the competitive field of cancer re...

Novo Nordisk Set to Slash Victoza Production to Boost Ozempic Supply

Novo Nordisk Set to Slash Victoza Production to Boost O...

Nov 24, 2023

In response to the escalating demand for its GLP-1 weight loss products, Novo No...

Merck to Purchase Caraway Therapeutics For Over $600M

Merck to Purchase Caraway Therapeutics For Over $600M

Nov 24, 2023

Merck & Co. has openly expressed its continuous pursuit of acquisitions, and cur...

NanoString Faces Setback in Patent Infringement Case Against Genomics

NanoString Faces Setback in Patent Infringement Case Ag...

Nov 24, 2023

In a recent legal skirmish in the biotechnology sector, NanoString finds itself ...

InDex’s Ulcerative Colitis Drug Experiences Failure in Phase 3 Review

InDex’s Ulcerative Colitis Drug Experiences Failure in ...

Nov 24, 2023

The Swedish biotech InDex has delivered surprising news to investors, announcing...

Novo Nordisk announces €2.1 billion commitment to France

Novo Nordisk announces €2.1 billion commitment to France

Nov 24, 2023

Novo Nordisk has announced a substantial investment of €2.1 billion to expand it...

Lilly plans to construct a $2.5 billion manufacturing facility in Germany

Lilly plans to construct a $2.5 billion manufacturing f...

Nov 22, 2023

Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct...

17
18
19
20
21